Advance Search
ZHAO Caihong, LIU Donghong, LI Weilin. Effect of rabetalol combined with low-dose aspirin on serum levels of miR-181b and miR-210 in pregnant women with hypertension disorders[J]. Journal of Clinical Medicine in Practice, 2020, 24(16): 57-60. DOI: 10.7619/jcmp.202016016
Citation: ZHAO Caihong, LIU Donghong, LI Weilin. Effect of rabetalol combined with low-dose aspirin on serum levels of miR-181b and miR-210 in pregnant women with hypertension disorders[J]. Journal of Clinical Medicine in Practice, 2020, 24(16): 57-60. DOI: 10.7619/jcmp.202016016
shu

Effect of rabetalol combined with low-dose aspirin on serum levels of miR-181b and miR-210 in pregnant women with hypertension disorders

  • Xi'an Gaoxin Hospital, Xi'an, Shaanxi, 710075

More Information
  • Received Date: May 25, 2020
  • Available Online: September 14, 2020
    Graphical Abstract
    • Abstract
  • Objective To explore the effect of rabetalol combined with low-dose aspirin in the treatment of hypertension disorders and influences on the expression of microRNA-181b(miR-181b)and microRNA-210(miR-210). Methods A total of 150 patients with hypertension during pregnancy were randomly divided into study group and control group, with 75 cases in each group. The control group was treated with labelol, and the patients in the study group were treated with low-dose aspirin enteric-coated tablets. The clinical efficacy, coagulation function, adverse pregnancy outcomes, serum miR-181b and miR-210 expression levels were compared between the two groups. Results After treatment, the clinical efficacy of the study group was significantly higher than that in the control group(P<0.05); prothrombin time(PT), activated partial thromboplastin time(APTT)and plasma thrombin time(TT)were all significantly longer than those in the control group, the levels of plasma fibrinogen(Fib)and D-dimer were significantly lower than the control group(P<0.05); the incidence of adverse pregnancy outcomes in the study group was significantly lower than that in the control group(P<0.05); the expression levels of serum miR-18b and miR-210 in the study group were significantly lower than those in the control group(P<0.05). Conclusion Labelol combined with low-dose aspirin has a good clinical effect for patients with gestational hypertension, which can effectively improve the coagulation function, decrease the incidence of adverse pregnancy outcomes, and reduce the expression levels of serum miR-181b and miR-210.
    • FullText(HTML)
    • References (16)
  • 王霞, 李庆, 麦燕, 等. 平肝熄风汤联合拉贝洛尔对妊娠期高血压血液动力变化及妊娠结局的影响[J]. 中华中医药学刊, 2018, 36(10): 2554-2557.
    陈芳转, 曾雪英, 王小兰, 等. 尼卡地平联合拉贝洛尔治疗妊娠期高血压患者的临床研究[J]. 中国临床药理学杂志, 2018, 34(23): 2700-2703.
    马晨涵, 裘雅芬. 拉贝洛尔注射液联合尼莫地平片治疗妊娠高血压的临床研究[J]. 中国临床药理学杂志, 2019, 35(11): 1102-1104.
    茹普霞, 王永红. 小剂量阿司匹林用于预防高危孕妇子痫前期的疗效观察[J]. 中西医结合心脑血管病杂志, 2017, 15(24): 3230-3232.
    刘怀昌, 肖磊, 徐智立, 等. 妊娠期高血压疾病对孕妇动脉弹性和血管内皮功能的影响[J]. 中华高血压杂志, 2019, 27(4): 372-375.

    .
    SONG J K, YE A Z, JIANG E L, et al. Reconstruction and analysis of the aberrant lncRNA-miRNA-mRNA network based on competitive endogenous RNA in CESC[J]. J Cell Biochem, 2018, 119(8): 6665-6673.
    吴琳琳, 周欣, 牛建民. 《妊娠期高血压疾病: 国际妊娠期高血压研究学会分类、诊断和管理指南(2018)》解读[J]. 中国实用妇科与产科杂志, 2018, 34(7): 758-763.
    RIISE HKR, SULO G, TELL GS, et al. Association Between Gestational Hypertension and Risk of Cardiovascular Disease Among 617?589 Norwegian Women[J]. Journal of the American Heart Association, 2018, 7(10): 8337-8337.
    周静, 王毅, 朱彦菲. 拉贝洛尔注射液联合硝苯地平控释片治疗妊娠高血压的临床研究[J]. 中国临床药理学杂志, 2018, 34(11): 1315-1317.
    朱君花, 雷侠. 高风险子痫前期孕妇妊娠期高血压疾病影响因素的临床研究[J]. 中国实验诊断学, 2017, 21(2): 250-253.
    LI B Y, YANG H X, ZHANG W Y, et al. Fatty acid-binding protein 4 predicts gestational hypertension and preeclampsia in women with gestational diabetes mellitus[J]. PLoS One, 2018, 13(2): 192-197.
    周丽佳, 陆月梅, 王秀美. 阿司匹林联合硫酸镁对轻度妊娠高血压患者血压控制、血液黏度、尿蛋白和尿素氮水平的影响[J]. 新疆医科大学学报, 2018, 41(8): 957-959.
    吴丽琴, 孙玉娟, 苏翠珍, 等. 低分子量肝素钠注射液联合硫酸镁注射液和拉贝洛尔片治疗重度妊娠期高血压综合征的临床研究[J]. 中国临床药理学杂志, 2019, 35(3): 216-219.
    梁小庄, 杨彩虹, 杨弋. 小剂量阿司匹林肠溶片对妊娠高血压综合征高危患者凝血功能的改善效果分析[J]. 吉林医学, 2017, 38(9): 1715-1716.
    邹纯才, 鄢海燕, 王莉丽, 等. 基于网络药理学分析瓜蒌阿司匹林配伍抗血小板聚集和抗血栓的作用机制研究[J]. 中国中药杂志, 2019, 44(8): 1654-1659.
    胡际东, 温丽, 郭珍, 等. 血清miR-181b及miR-210在妊娠期高血压疾病中表达及与炎性细胞因子的相关性[J]. 中华实用诊断与治疗杂志, 2019, 33(3): 241-244.
    • Related Articles

  • Related Articles

    [1]PAN Yongna, KANG Jinwang, CHANG Yuefeng. Expressions of lncRNA ANRIL and miR-181b-5p in the serum of patients with colon cancer complicated with type 2 diabetes mellitus and their correlations with lymph node metastasis[J]. Journal of Clinical Medicine in Practice, 2025, 29(2): 32-37. DOI: 10.7619/jcmp.20242987
    [2]CUI Xin, YAN Xiaowen, SUN Xiao, FU Yanyan, TAO Ran. Correlations of the expression levels of plasma long non-coding RNA plasmacytoma variant translocation 1 and microRNA-143-3p with disease activity and prognosis in patients with rheumatoid arthritis[J]. Journal of Clinical Medicine in Practice, 2024, 28(24): 82-87. DOI: 10.7619/jcmp.20243912
    [3]ZHANG Min, WANG Jinping, HE Yong. Lidocaine inhibits hypoxia/reoxygenation-induced cardiomyocyte damage by down-regulating microRNA-181a[J]. Journal of Clinical Medicine in Practice, 2024, 28(3): 68-73. DOI: 10.7619/jcmp.20233357
    [4]MA Cunliang, GENG Qingya. Evaluation value of serum microRNA-19b-3p and microRNA-933 levels on cardiac function and prognosis in elderly patients with chronic heart failure[J]. Journal of Clinical Medicine in Practice, 2024, 28(3): 63-67. DOI: 10.7619/jcmp.20233416
    [5]Kabinuer·ALIMASI, CHEN Hailin, Aishanjiang·MUHETAER, Maimaitirexiati·SUPAJI, WU Chunping, Anniwaer·MAIMAITI. Effect of long non-coding RNA SLCO4A1-AS1 targeting microRNA-615-5p on the proliferation, apoptosis and inflammatory factors expression in esophageal cancer cells[J]. Journal of Clinical Medicine in Practice, 2024, 28(1): 13-19. DOI: 10.7619/jcmp.20233173
    [6]HAO Runmei, LIU Jing, LIU Jie, ZHANG Ting. Expression and clinical significance of long non-coding RNA X-inactive specific transcript and microRNA-146-5p in thyroid carcinoma[J]. Journal of Clinical Medicine in Practice, 2023, 27(5): 72-75, 81. DOI: 10.7619/jcmp.20223262
    [7]ZHANG Yu, ZHANG Can, ZHANG Weiling. Mechanism of long non-coding RNA NR2F1-AS1 regulates proliferation and apoptosis of ovarian cancer cells by targeting microRNA-493-5p expression[J]. Journal of Clinical Medicine in Practice, 2023, 27(4): 30-34. DOI: 10.7619/jcmp.20222967
    [8]DENG Lin, XIE Luli, LI Kun. Effects of long non-coding RNA LINC01139 in regulating proliferation, migration and invasion of oral squamous cell carcinoma cisplatin-resistant cells by targeting microRNA-300[J]. Journal of Clinical Medicine in Practice, 2022, 26(5): 86-90. DOI: 10.7619/jcmp.20214197
    [9]LIU Mingtao, PANG Yanrong, ZHAO Liang, WEN Zhongzheng, HOU Guoqing. Expression and clinical significance of microRNA-210 and lipoprotein-associated phospholipase A2 in patients with coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2021, 25(21): 39-42. DOI: 10.7619/jcmp.20212085
    [10]YANG Jie, WANG Benxiao, WANG Junjun. Correlations between serum microRNA-210, interleukin-17 levels and degree of carotid artery stenosisin patients with acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2021, 25(11): 31-34. DOI: 10.7619/jcmp.20211119

Catalog

    Get Citation
    PDF
    XML
    Article views (336) PDF downloads (8) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return